|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Retaspimycin>> Market Analysis Reports |
Market Analysis Reports of Retaspimycin |
|
Retaspimycin (CAS 857402-23-4) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Global Market Report of Retaspimycin (CAS 857402-23-4) December 2024 CAS 857402-23-4 Retaspimycin Chemical Report & Database ... Report & Database definitions: Name: Retaspimycin: Retaspimycin; 18,21-Didehydro-17-demethoxy-18,21-dideoxo-18,21-dihydroxy-17-(2-propenylamino ... APPLICATIONS: Chemical or Reaction Intermediate The Retaspimycin Report & Database gives Market Consumption ... Infinity Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... s primary product candidate, IPI-504 (retaspimycin hydrochloride), is an intravenously-administered small molecule ... inhibitor of Hsp90. IPI-504 (retaspimycin hydrochloride) is a small molecule, semi-synthetic ... Drivers of M&A in 2013-2016: PI3Ks and BTK Inhibitors Targeting kinases have been on the agenda of most drug developers/ researchers as they hold the key path to signaling, development and growth of the cell. Tumors/cancer biology indicates that this balance is disturbed and inhibiting the aberrant pathways ... |